Compare eBay Inc (EBAY) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Twist Bioscience Corp — how do they compare? eBay Inc trades at $111.7 (market cap $47.88B), while Twist Bioscience Corp trades at $158 (market cap $10.32B). The key difference: eBay Inc is far larger — about 4.6× Twist Bioscience Corp's market cap, and eBay Inc pays a 1.15% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Twist Bioscience Corp for 27 Days on average.
| EBAY | TWST | |
|---|---|---|
Market Cap | $47.88B | $10.32B |
Volume | 2,781,198 | 5,894,998 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $205.00 |
52-Week Low | $79.41 | $25.45 |
Typical Hold Time | 134 Days | 27 Days |
Enterprise Value | $51.71B | $10.24B |
Dividend Yield | 1.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $111.98, up 4.6% with bullish technical signals and strong earnings momentum after beating Q2 2026 estimates. The company maintains robust profitability with 72% gross margins and 47% ROE, while analyst consensus targets $117.68. Recent news highlights strategic focus on collectibles and live commerce growth, though GameStop's acquisition interest and executive selling warrant monitoring.
EBAY presents a balanced investment case with solid fundamentals and positive technicals, but faces competitive pressures from Amazon's multi-platform tools and potential acquisition uncertainty. The stock offers moderate upside to consensus targets with execution-dependent growth in key verticals.
TWST trades at $152.05, down 8.94% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $376.57 million in 2025, but profitability remains elusive with a net income margin of -31.66%. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, providing a potential growth catalyst amid ongoing losses.
The outlook is mixed; analyst consensus is bullish with a $145.20 price target, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on the company's ability to monetize its AI collaborations and achieve profitability, while downside risks include cash burn and competitive pressures in the biotech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
